Literature DB >> 28779554

Cytokine responses to exercise and activity in patients with chronic fatigue syndrome: case-control study.

L V Clark1, M Buckland2, G Murphy2, N Taylor2, V Vleck3, C Mein4, E Wozniak4, M Smuk1, P D White1.   

Abstract

Chronic fatigue syndrome (CFS) is characterized by fatigue after exertion. A systematic review suggested that transforming growth factor (TGF)-β concentrations are often elevated in cases of CFS when compared to healthy controls. This study attempted to replicate this finding and investigate whether post-exertional symptoms were associated with altered cytokine protein concentrations and their RNA in CFS patients. Twenty-four patients fulfilling Centers for Disease Control criteria for CFS, but with no comorbid psychiatric disorders, were recruited from two CFS clinics in London, UK. Twenty-one healthy, sedentary controls were matched by gender, age and other variables. Circulating proteins and RNA were measured for TGF-β, tumour necrosis factor (TNF), interleukin (IL)-8, IL-6 and IL-1β. We measured six further cytokine protein concentrations (IL-2, IL-4, IL-5, IL-10, IL-12p70, and interferon (IFN)-γ). Measures were taken at rest, and before and after both commuting and aerobic exercise. CFS cases had higher TGF-β protein levels compared to controls at rest (median (quartiles) = 43·9 (19·2, 61·8) versus 18·9 (16·1, 30·0) ng/ml) (P = 0·003), and consistently so over a 9-day period. However, this was a spurious finding due to variation between different assay batches. There were no differences between groups in changes to TGF-β protein concentrations after either commuting or exercise. All other cytokine protein and RNA levels were similar between cases and controls. Post-exertional symptoms and perceived effort were not associated with any increased cytokines. We were unable to replicate previously found elevations in circulating cytokine concentrations, suggesting that elevated circulating cytokines are not important in the pathophysiology of CFS.
© 2017 British Society for Immunology.

Entities:  

Keywords:  TGF-β; chronic fatigue syndrome; cytokines; exercise; myalgic encephalomyelitis

Mesh:

Substances:

Year:  2017        PMID: 28779554      PMCID: PMC5680051          DOI: 10.1111/cei.13023

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  38 in total

Review 1.  Evidence for the presence of immune dysfunction in chronic fatigue syndrome.

Authors:  Benjamin H Natelson; Mohammad H Haghighi; Nicholas M Ponzio
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

Review 2.  A systematic review and critical evaluation of the immunology of chronic fatigue syndrome.

Authors:  Marc Lyall; Mark Peakman; Simon Wessely
Journal:  J Psychosom Res       Date:  2003-08       Impact factor: 3.006

3.  Perceived exertion as an indicator of somatic stress.

Authors:  G Borg
Journal:  Scand J Rehabil Med       Date:  1970

Review 4.  Chronic fatigue syndrome: neurological findings may be related to blood--brain barrier permeability.

Authors:  A C Bested; P R Saunders; A C Logan
Journal:  Med Hypotheses       Date:  2001-08       Impact factor: 1.538

Review 5.  Chronic fatigue syndrome and circulating cytokines: A systematic review.

Authors:  S Blundell; K K Ray; M Buckland; P D White
Journal:  Brain Behav Immun       Date:  2015-07-03       Impact factor: 7.217

6.  Development of a fatigue scale.

Authors:  T Chalder; G Berelowitz; T Pawlikowska; L Watts; S Wessely; D Wright; E P Wallace
Journal:  J Psychosom Res       Date:  1993       Impact factor: 3.006

7.  Transcriptional regulation of gene expression in human skeletal muscle during recovery from exercise.

Authors:  H Pilegaard; G A Ordway; B Saltin; P D Neufer
Journal:  Am J Physiol Endocrinol Metab       Date:  2000-10       Impact factor: 4.310

Review 8.  Chronic fatigue syndrome.

Authors:  Judith B Prins; Jos W M van der Meer; Gijs Bleijenberg
Journal:  Lancet       Date:  2006-01-28       Impact factor: 79.321

9.  Active and acid-activatable TGF-beta in human sera, platelets and plasma.

Authors:  D J Grainger; D E Mosedale; J C Metcalfe; P L Weissberg; P R Kemp
Journal:  Clin Chim Acta       Date:  1995-02-28       Impact factor: 3.786

10.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.

Authors:  Jo Vandesompele; Katleen De Preter; Filip Pattyn; Bruce Poppe; Nadine Van Roy; Anne De Paepe; Frank Speleman
Journal:  Genome Biol       Date:  2002-06-18       Impact factor: 13.583

View more
  9 in total

1.  Cytokine signature in chronic fatigue syndrome.

Authors:  Megan E Roerink; Matthew Buckland; Andrew R Lloyd; Jos W M van der Meer
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-30       Impact factor: 11.205

2.  Cytokine signatures in chronic fatigue syndrome patients: a Case Control Study and the effect of anakinra treatment.

Authors:  Megan E Roerink; Hans Knoop; Ewald M Bronkhorst; Henk A Mouthaan; Luuk J A C Hawinkels; Leo A B Joosten; Jos W M van der Meer
Journal:  J Transl Med       Date:  2017-12-29       Impact factor: 5.531

3.  Value of Circulating Cytokine Profiling During Submaximal Exercise Testing in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  Kegan J Moneghetti; Mehdi Skhiri; Kévin Contrepois; Yukari Kobayashi; Holden Maecker; Mark Davis; Michael Snyder; Francois Haddad; Jose G Montoya
Journal:  Sci Rep       Date:  2018-02-09       Impact factor: 4.379

Review 4.  Infection Elicited Autoimmunity and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An Explanatory Model.

Authors:  Jonas Blomberg; Carl-Gerhard Gottfries; Amal Elfaitouri; Muhammad Rizwan; Anders Rosén
Journal:  Front Immunol       Date:  2018-02-15       Impact factor: 7.561

Review 5.  The clinical value of cytokines in chronic fatigue syndrome.

Authors:  Tiansong Yang; Yan Yang; Delong Wang; Chaoran Li; Yuanyuan Qu; Jing Guo; Tianyu Shi; Wang Bo; Zhongren Sun; Tetsuya Asakawa
Journal:  J Transl Med       Date:  2019-06-28       Impact factor: 5.531

6.  Rethinking ME/CFS Diagnostic Reference Intervals via Machine Learning, and the Utility of Activin B for Defining Symptom Severity.

Authors:  Brett A Lidbury; Badia Kita; Alice M Richardson; Donald P Lewis; Edwina Privitera; Susan Hayward; David de Kretser; Mark Hedger
Journal:  Diagnostics (Basel)       Date:  2019-07-19

7.  Circadian rhythm disruption in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for the post-acute sequelae of COVID-19.

Authors:  Michael J McCarthy
Journal:  Brain Behav Immun Health       Date:  2022-01-10

8.  Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Authors:  Jacqueline M Cliff; Elizabeth C King; Ji-Sook Lee; Nuno Sepúlveda; Asia-Sophia Wolf; Caroline Kingdon; Erinna Bowman; Hazel M Dockrell; Luis Nacul; Eliana Lacerda; Eleanor M Riley
Journal:  Front Immunol       Date:  2019-04-16       Impact factor: 7.561

9.  Exogenous Transforming Growth Factor-β in Brain-Induced Symptoms of Central Fatigue and Suppressed Dopamine Production in Mice.

Authors:  Won Kil Lee; Yeongyeong Kim; Heejin Jang; Joo Hye Sim; Hye Jin Choi; Younmin Shin; Jeong June Choi
Journal:  Int J Mol Sci       Date:  2021-03-04       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.